Beam Therapeutics (BEAM) EBT Margin Growth (5y) (2024 - 2026)

Beam Therapeutics (BEAM) EBT Margin Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Beam Therapeutics 3.53 Bn 3.53 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 333.96 Mn
Dec 31, 2025 67.96 Mn
Sep 30, 2025 61.80 Mn
Jun 30, 2025 43.27 Mn
Mar 31, 2025 46.12 Mn
Dec 31, 2024 43.39 Mn
Sep 30, 2024 28.94 Mn
Jun 30, 2024 28.02 Mn